HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seokyoung Lee Selected Research

rho-Associated Kinases

1/2021In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seokyoung Lee Research Topics

Disease

1Uveal melanoma
01/2021
1Neoplasms (Cancer)
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Macular Degeneration (Age-Related Maculopathy)
06/2011
1Retinal Diseases
06/2011
1Retinitis Pigmentosa (Pigmentary Retinopathy)
06/2011

Drug/Important Bio-Agent (IBA)

11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2021
1K-115IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1rho-Associated KinasesIBA
01/2021

Therapy/Procedure

1Immunotherapy
01/2021
1Photochemotherapy (Photodynamic Therapy)
01/2021
1Therapeutics
01/2021
1Visual Prosthesis
06/2011